FE HLDGS INTL (00036) issued a profit alert, expecting to achieve an audited profit of approximately HKD 14 million for the interim period, a turnaround from a loss compared to the same period last year.
Far East Holdings International (00036) announced that, based on a preliminary review of the Group's unaudited financial information for the six months ended June 30, 2026 (the "Period"), the Group expects to achieve an audited profit of approximately HKD 14 million for this Period, compared to a loss of approximately HKD 18 million for the six months ended June 30, 2025. The expected profit is primarily due to the fair value gains from investment properties during this Period.
FE HLDGS INTL (00036) announced that, based on a preliminary review of the unaudited financial information of the Group for the six months ending June 30, 2026 (the Period), the Group expects to achieve an audited profit of approximately HKD 14 million for the Period, compared to a loss of approximately HKD 18 million for the six months ending June 30, 2025. The expected profit is primarily due to the fair value gains on investment properties during the Period.
Related Articles

HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.

BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.
HJ SCIENCE-B (06132) recommends adopting the H-share incentive plan for 2026.

SKB BIO (06990) released its interim results, with shareholders' net profit reaching 388 million yuan, marking a turnaround from loss to profit compared to the same period last year.

BlackRock increased its holdings in INNOVENT BIO (01801) by 139,500 shares at a price of HKD 95.375 per share.

RECOMMEND





